
GC35309
Alrestatin sodium
Also known as sodium 2-(1,3-dioxobenzo[de]isoquinolin-2-yl)acetate
Alrestatin sodium is an inhibitor of aldose reductase, an enzyme involved in the pathogenesis of complications of diabetes mellitus, including diabetic neuropathy
ChemicalCAS51876-97-2MW277.21FormulaC14H8NNaO4
- CAS number
- 51876-97-2
- Molecular weight
- 277.21
- Formula
- C14H8NNaO4
- Solubility
- Soluble in DMSO
- InChIKey
- FKZUETPACPDEAD-UHFFFAOYSA-M
- Catalogue number
- GC35309
- Brand
- GLPBIO
Computed properties PubChem CID 23683779 · TPSA 77.5 Ų · H-bond donors 0 · H-bond acceptors 4
- TPSA
- 77.5 Ų
- H-bond donors
- 0
- H-bond acceptors
- 4
- Rotatable bonds
- 2
- Heavy atoms
- 20
SMILES C1=CC2=C3C(=C1)C(=O)N(C(=O)C3=CC=C2)CC(=O)[O-].[Na+]
Computed descriptors from PubChem (CID 23683779), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il